From: Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Status | Cost (€) |
---|---|
Relapse (hospital cost) | 5,589 (1) [32] |
Acute EPS (extra-pyramidal symptoms) | 85 (2) |
Psychiatric medical visit | 68 [42] |
Biperidene (2 mg/8 h/day) | 17 [31] |
Weight gain | 117 (3) |
General physician medical visit | 39 [42] |
Diabetes Mellitus (control) | |
Amputation | 5,857 [36] |
Fatal myocardial infarction | 1,531 [37] |
Heart failure | 4,189 [38] |
Ischaemic heart disease | 2,474 [39] |
Non-fatal myocardial infarction | 21,610 [37] |
Non-fatal Stroke | 5,199 [40] |